Ocugen Statistics
NASDAQ: OCGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.7679+0.0351 (+4.79%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ocugen by the numbers
Ocugen has a market capitalization of $260.6 million based on 339.31M shares outstanding. With trailing EPS of $-0.20, Ocugen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.2% below its 50-day average and 44.1% below its 200-day average.
Average daily trading volume is 7.34M shares, or about $5.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
OCGN valuation vs. peer median
| Metric | OCGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $260.55M | $255.00M | +2% |
| Avg. volume | 7.34M | 885.38K | +729% |
Peer median across 8 companies: EIKN, SABS, EDIT, AGMB, KYTX, AGEN, LXEO, PLX.
Valuation
- Market cap
- $260.55M
- Price / sales (latest FY)
- 59.04
- EPS (TTM)
- $-0.20
- Shares outstanding
- 339.31M
Price and trading
- Previous close
- 0.7328
- Open
- 0.71
- Day range
- 0.71 – 0.8198
- 52-week range
- 0.691 – 2.73
- 52-week change
- -33.80%
- 50-day moving average
- 0.8951
- Beta
- —
- Volume
- 6.19M
- Average volume
- 7.34M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 260.55M
- Forward Pe
- -4.27
- Eps
- -0.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.73
- Week52 Low
- 0.69
- Avg Volume
- 7.34M
- Shares Outstanding
- 339.31M
- Ma50
- 0.90
- Ma200
- 1.37
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -71.82%
- Pct From52w Low
- 11.13%